Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
:CBLL
CBLL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.01 - $32.75
Previous CloseN/A
Volume46.56K
Average Volume (3M)225.09K
Market Cap
$399.93M
Enterprise Value$755.40M
Total Cash (Recent Filing)$194.37M
Total Debt (Recent Filing)$21.96M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Nov 18, 2025EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding35,868,340
10 Day Avg. Volume285,164
30 Day Avg. Volume225,090
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit13.31
Enterprise Value/Ebitda-21.20
Forecast
1Y Price Target
$33.25Price Target Upside198.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Ceribell, Inc. News
PremiumCompany Announcements
Ceribell, Inc. Addresses Impact of New U.S. Tariffs
PremiumCompany Announcements
Ceribell, Inc. Announces Executive Compensation Adjustments
PremiumCompany Announcements
CeriBell’s Earnings Call: Strong Growth Amid Challenges---
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationThe analyst's recommendation for Ceribell, Inc. is a 'BUY' with a price objective of 32.00 USD, significantly higher than the current price of 19.23 USD.
Financial PerformanceCeribell reported Q4/24 revenue of $18.5M, beating both the estimate and consensus.
Revenue GrowthCeribell issued 2025 revenue guidance of $81-$85m, above the Street’s $81m.
Bears Say
Gross Margin DeclineThe gross margin has been reduced from 85% to 71% due to the latest 145% incremental China tariff.
Manufacturing ChallengesCeribell faces an incremental 135% China tariff due to new measures, which affects the cost of goods sold for headbands imported from China.
Tariff ImpactTariffs of 145% on Chinese imports would decrease Ceribell’s gross margins by about 10 percentage points, impacting the company's profitability.
---
Ownership Overview
24.30% Insiders
15.35% Mutual Funds
36.45% Other Institutional Investors
20.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $10.01 and its highest was $32.75 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $399.93M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 219 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on Feb 25, 2025. The company reported -$0.4 earnings per share for the quarter, missing the consensus estimate of -$0.318 by -$0.082.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate is -0.32.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 35,868,340 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.4 in its last earnings report, missing expectations of -$0.318. Following the earnings report the stock price went down -1.331%.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
---
Ceribell, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.25 (198.21% Upside)
$33.25 (198.21% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $6.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.0%
Last 30 Days ▲ 8.8%
Last 30 Days ▲ 8.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Company Description
Ceribell, Inc.
Ceribell, Inc. (CBLL) is a medical technology company focused on developing and providing innovative solutions for rapid brain assessment. The company specializes in creating portable, easy-to-use devices designed to diagnose neurological conditions, with a particular emphasis on epilepsy and other seizure-related disorders. Ceribell's core product, the Rapid Response EEG system, aims to provide real-time brain monitoring to improve patient outcomes in critical care settings.
---
CBLL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
CeriBell demonstrated strong revenue growth and maintained high gross margins, successfully expanded its account base, and completed a successful IPO. However, increased operating expenses, a higher net loss, and tariffs on materials from China are notable challenges. Overall, the highlights outweigh the lowlights, indicating a positive sentiment for the earnings call.Read More>---
CBLL Stock 12 Month Forecast
Average Price Target
$33.25
▲(198.21% Upside)
Technical Analysis
Best Analysts Covering CBLL
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-16.73%
reiterated a buy rating 3 days ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -16.73% per trade.
---